ISP-4-6 Three-combined treatment, a novel HDAC inhibitor OBP-801/YM753, paclitaxel and 5-fluorouracil synergistically induces G2-cell cycle arrest in human ovarian cancer SKOV-3 cells(Group 4 Oncology 4,IS Poster,International Session)